Ziziphus spina-christi extract alleviate Cisplatin induced hepatorenal toxicity in rat via oxidative stress and apoptosis modulation
Keywords:
Cisplatin , Ziziphus spina-christi oil extract , Gas-chromatography , TNF alpha , AnticancerAbstract
Cisplatin is famous, effective anti-cancer drug but has some adverse effects such as nephrotoxicity and hepatotoxicity. This work was planned to assess the protective effect of Ziziphus spina-christi oil extract against Cisplatin induced hepatorenal toxicity. A total of 24 male albino rats divided into equal four groups for 14 consecutive days. G1(control), G2(ziziphus spina-christi), G3(cisplatin), G4(cisplatin+ ziziphus spina-christi). Cisplatin treated rats showed increase serum of AST, ALP, ALT, triglyceride, cholesterol, LDL- cholesterol, urea, creatinine concentrations and decreased total protein and albumin concentration. Furthermore, cisplatin treated rats significantly increased the MDA level and decreased both of CAT and SOD levels in hepatic and renal tissue compared to control. Administration of Ziziphus spina-christi oil extract orally at dose of with once intraperitoneal IP at 10th day of experiment renormalized cisplatin hepatorenal damaged group by exerting antioxidant, anti-inflammatory and anticancer effects. Both of histopathological and immunohistochemical (TNF alpha) examination showed good changes, recorrection after using of Ziziphus Spina-Christi oil extract orally.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Journal of Advanced Veterinary Research
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles under the following conditions: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0).
Attribution-NonCommercial-NoDerivs
CC BY-NC-ND
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license